Susanna Perez-Gutthann (Susana Perez-Gutthann)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Clinical Practice

Cross Sectional

Muscular Dystrophy

Top Venues

Pharmacoepidemiology and drug safety

International journal of chronic obstructive pulmonary disease

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Rosa Gini, Romin Pajouheshnia, Lia Gutiérrez, Morris A Swertz, Eleanor Hyde, Miriam C J M Sturkenboom, Alejandro Arana, Carla Franzoni, Vera Ehrenstein, Giuseppe Roberto, Miguel Gil, Miguel-Angel Maciá-Martínez, Wiebke Schäfer, Ulrike Haug, Nicolas H Thurin, Régis Lassalle, Cécile Droz-Perroteau, Silvia Zaccagnino, Maria Paula Busto, Bas Middelkoop, Karin Gembert, Francisco Sanchez-Saez, Clara L Rodríguez-Bernal, Gabriel Sanfélix-Gimeno, Isabel Hurtado, Manuel Barreiro-de Acosta, Beatriz Poblador-Plou, Jonás Carmona Píréz, Antonio Gimeno-Miguel, Alexandra Prados-Torres, Anna Schultze, Ella Jansen, Ron M C Herings, Josephina G Kuiper, Igor Locatelli, Janja Jazbar, Špela Žerovnik, Mitja Kos, Steven Smit, Sirje Lind, Andres Metspalu, Stefania Simou, Karin Hedenmalm, Ana Cochino, Paolo Alcini, Xavier Kurz, Susanna Perez-Gutthann
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe. Pharmacoepidemiology and drug safety 33 (8) (2024)
Romin Pajouheshnia, Rosa Gini, Lia Gutiérrez, Morris A Swertz, Eleanor Hyde, Miriam C J M Sturkenboom, Alejandro Arana, Carla Franzoni, Vera Ehrenstein, Giuseppe Roberto, Miguel Gil, Miguel-Angel Maciá-Martínez, Wiebke Schäfer, Ulrike Haug, Nicolas H Thurin, Régis Lassalle, Cécile Droz-Perroteau, Silvia Zaccagnino, Maria Paula Busto, Bas Middelkoop, Karin Gembert, Francisco Sanchez-Saez, Clara L Rodríguez-Bernal, Gabriel Sanfélix-Gimeno, Isabel Hurtado, Manuel Barreiro-de Acosta, Beatriz Poblador-Plou, Jonás Carmona Píréz, Antonio Gimeno-Miguel, Alexandra Prados-Torres, Anna Schultze, Ella Jansen, Ron M C Herings, Josephina G Kuiper, Igor Locatelli, Janja Jazbar, Špela Žerovnik, Mitja Kos, Steven Smit, Sirje Lind, Andres Metspalu, Stefania Simou, Karin Hedenmalm, Ana Cochino, Paolo Alcini, Xavier Kurz, Susanna Perez-Gutthann
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe. Pharmacoepidemiology and drug safety 33 (8) (2024)
Stefan de Vogel, John D Seeger, Alejandro Arana, Andrea V Margulis, Lisa J McQuay, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Marie Linder, Ingvild Odsbu, Brandon Suehs, Yihua Xu, Claudia Uribe, Kwame Appenteng, Noah Jamie Robinson
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program. Pharmacoepidemiology and drug safety 33 (5) (2024)
Stefan de Vogel, John D Seeger, Alejandro Arana, Andrea V Margulis, Lisa J McQuay, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Marie Linder, Ingvild Odsbu, Brandon Suehs, Yihua Xu, Claudia Uribe, Kwame Appenteng, Noah Jamie Robinson
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program. Pharmacoepidemiology and drug safety 33 (5) (2024)
Raphaelle Beau-Lejdstrom, Lai San Hong, Xabier Garcia de Albeniz, Florin Floricel, Johan Lorenzen, Francois Bonfitto, Linda Kalilani, Christian Loesch, Graham Luscombe, Susanna Perez-Gutthann, Isabelle Mottet, Nadia Foskett
Incidence of Acute Renal Failure in Patients Using Levetiracetam Versus Other Antiseizure Medications: A Voluntary Post-Authorization Safety Study. Drug safety 45 (7) (2022)
Cristina Rebordosa, Estel Plana, Annalisa Rubino, Jaume Aguado, David Martinez, Alejhandra Lei, Sami Daoud, Nuria Saigi-Morgui, Susanna Perez-Gutthann, Elena Rivero-Ferrer
Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. International journal of chronic obstructive pulmonary disease 17 (2022)
Shirley V Wang, Jesper Hallas, William Crown, Peter Arlett, Darren M Ashcroft, Eric I Benchimol, Marc L Berger, Gracy Crane, Wim Goettsch, Wei Hua, Shaum Kabadi, David M Kern, Xavier Kurz, Sinead Langan, Takahiro Nonaka, Lucinda Orsini, Susanna Perez-Gutthann, Simone Pinheiro, Nicole L Pratt, Sebastian G Schneeweiss, Massoud Toussi, Rebecca J Williams
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force. Pharmacoepidemiology and drug safety (2022)
Elena Rivero-Ferrer, Morten Olesen, Estel Plana, Jaume Aguado, Nuria Saigi-Morgui, Annalisa Rubino, Sami Z Daoud, Alejhandra Lei, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Jesper Hallas, Cristina Rebordosa, Cristina Rebordosa
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clinical drug investigation 42 (4) (2022)
Joan Fortuny, Gero von Gersdorff, Régis Lassalle, Marie Linder, Jetty A Overbeek, Jonas Reinold, Gunnar Toft, Antje Timmer, Jochen Dress, Patrick Blin, Cécile Droz-Perroteau, Vera Ehrenstein, Carla Franzoni, Ron M C Herings, Bianca Kollhorst, Nicholas Moore, Ingvild Odsbu, Susanna Perez-Gutthann, Cristina Rebordosa, Katherine Rascher, Lawrence Rasouliyan, Kenneth J Rothman, Nuria Saigi-Morgui, Mathias Schaller, Elisabeth Smits, Michael Forstner, null null, Jacques Benichou, Andreas J Bircher, Edeltraut Garbe, David S Rampton, Lia Gutiérrez
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe. Pharmacoepidemiology and drug safety 30 (10) (2021)
Jesper Hallas, Lucas Morin, Nina Sahlertz Kristiansen, Tobias Gerhard, Almut G Winterstein, Susanna Perez-Gutthann, Mina Tadrous
Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology. Pharmacoepidemiology and drug safety (2021)
Alejandro Arana, Jesper Hallas, Josephina G Kuiper, Helen Booth, Johan Reutfors, Brian Calingaert, Lars Christian Lund, Elizabeth Crellin, Marcus Schmitt-Egenolf, James A Kaye, Karin Gembert, Kenneth J Rothman, Helle Kieler, Daniel Dedman, Eline Houben, Lia Gutiérrez, Nina Sahlertz Kristiansen, Susanna Perez-Gutthann
Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE). Clinical epidemiology 13 (2021)
Cristina Rebordosa, Estel Plana, Annalisa Rubino, Jaume Aguado, Alejhandra Lei, Sami Daoud, Nuria Saigi-Morgui, Susanna Perez-Gutthann, Elena Rivero-Ferrer
A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink. International journal of chronic obstructive pulmonary disease 16 (2021)
Veena Hoffman, Nina Sahlertz Kristiansen, Marie Linder, Andrea V Margulis, Brandon T Suehs, Alejandro Arana, Kelesitse Phiri, Cheryl Enger, Libby Horter, Ingvild Odsbu, Morten Olesen, Susanna Perez-Gutthann, Yihua Xu, Nina Sahlertz Kristiansen, Kwame Appenteng, Stefan de Vogel, John D Seeger, null null
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study. Drug safety 44 (8) (2021)
Alejandro Arana, Andrea V Margulis, Cristina Varas-Lorenzo, Christine L Bui, Alicia W Gilsenan, Lisa J McQuay, Maria Reynolds, Cristina Rebordosa, Billy Franks, Stefan de Vogel, Kwame Appenteng, Susanna Perez-Gutthann
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom. Pharmacoepidemiology and drug safety 30 (2) (2020)
Antje Timmer, Dominik de Sordi, Sanny Kappen, Klaus Peter Kohse, Cristina Rebordosa, Susanna Perez-Gutthann, Emmanuelle Jacquot, Nicolas Deltour, Manel Pladevall
Validity of hospital ICD-10-GM codes to identify acute liver injury in Germany. Pharmacoepidemiology and drug safety 28 (10) (2019)
Cristina Rebordosa, Estel Plana, Jaume Aguado, Steven Thomas, Esther García-Gil, Susanna Perez-Gutthann, Jordi Castellsague
GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiology and drug safety 28 (2) (2018)
Xavier Kurz, Susanna Perez-Gutthann, null null
Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Pharmacoepidemiology and drug safety 27 (3) (2018)
Jordi Castellsague, Beatriz Poblador-Plou, Maria Giner-Soriano, Marie Linder, Oliver Scholle, Brian Calingaert, Christine Bui, Alejandro Arana, Clara Laguna, Francisca Gonzalez-Rubio, Albert Roso-Llorach, Alexandra Prados-Torres, Susanna Perez-Gutthann
Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany. Pharmacoepidemiology and drug safety 27 (9) (2018)